Velocity Clinical Research Appoints UK Medical Director

Dr. Ronnie Beboso joins the organization to oversee UK physicians and provide strategic medical leadership.

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Velocity Clinical Research, a leading integrated site organization for clinical trials, has announced the appointment of Dr. Ronnie Beboso as the UK Medical Director. Dr. Beboso brings 20 years of experience in clinical research and will oversee all UK physicians, provide strategic medical leadership across the network, and support the evolution of Velocity's medical model as the company continues to scale its operations across the UK and Europe.

Why it matters

Velocity's appointment of an experienced UK Medical Director reflects the company's commitment to maintaining strong medical leadership as it expands its presence in Europe. This move ensures that patient care, physician development, and scientific rigor remain central to Velocity's clinical research model as the organization grows.

The details

In his new role, Dr. Beboso will be responsible for overseeing all UK physicians, providing strategic medical leadership across Velocity's network, and supporting the evolution of the company's medical model to meet the needs of its growing, pan-European organization. Dr. Beboso has a distinguished career in clinical research, having held senior research physician roles at IQVIA, Chiltern, Medinova, and Accellacare Clinical Research, where he worked on a wide range of therapeutic areas and conducted first-in-human, early-phase, and Phase II-IV clinical trials.

  • Dr. Beboso's appointment was announced on February 12, 2026.

The players

Velocity Clinical Research

A leading integrated site organization for clinical trials, with over 70 sites and more than 200 investigators across the U.S. and Europe.

Dr. Ronnie Beboso

A UK-registered physician with 20 years of experience in clinical research, who has been appointed as the UK Medical Director for Velocity Clinical Research.

Dr. Sarah Smiley

The Chief Physician Officer at Velocity Clinical Research.

Rachael Buck

The UK Country Head at Velocity Clinical Research.

Got photos? Submit your photos here. ›

What they’re saying

“As Velocity continues to establish and consolidate its European presence, it is essential that we maintain strong medical leadership alongside our commercial and operational capabilities. Ronnie brings credibility, depth, and a true medical perspective to the leadership team. His ability to mentor physicians, challenge us constructively, and help our investigators expand their therapeutic expertise will be critical to our long-term success. At our core, we are a medical organization and this role ensures that remains front and center.”

— Dr. Sarah Smiley, Velocity Chief Physician Officer (bakercityherald.com)

“Clinical trials allow physicians to help patients today while advancing treatments that will benefit patients tomorrow. What drew me to Velocity is the opportunity to combine hands-on clinical work with broader medical leadership, supporting physicians, spending meaningful time with patients, and contributing to the development of new medicines that can genuinely change lives.”

— Dr. Ronnie Beboso (bakercityherald.com)

“Dr. Beboso's appointment reflects Velocity's commitment to balancing scale with quality, ensuring that patient care, physician development, and scientific rigor remain at the heart of its clinical research model.”

— Rachael Buck, Velocity UK Country Head (bakercityherald.com)

The takeaway

Velocity Clinical Research's appointment of an experienced UK Medical Director, Dr. Ronnie Beboso, demonstrates the company's focus on maintaining strong medical leadership and ensuring that patient care, physician development, and scientific rigor remain central to its clinical research model as it continues to expand its operations across Europe.